Mergers & Acquisitions

MediQuant Receives Significant Growth Investment from Revelstoke Capital Partners

6045 MediQuant NT

M&A Engagement Overview

Industry Groups: Healthcare & Life Sciences; Technology
Areas of Focus: Healthcare IT; Outpatient; Infrastructure Software & Cybersecurity; Data Management; Compliance Software

Harris Williams advised MediQuant, LLC, a portfolio company of Silversmith Capital Partners, on their significant growth investment from Revelstoke Capital Partners. MediQuant is a leader in cloud-based data archiving and interoperability solutions for hospitals and health systems.

MediQuant plays on two key themes that are being discussed in boardrooms across the world – data and compliance. Through the company’s proprietary active data archiving technology, MediQuant enables the largest hospitals and health systems to capture data across clinical, financial, and administrative systems and move it to a common data model – which unlocks value and multiple use cases. Revelstoke has extensive experience building industry-leading healthcare businesses and will be an excellent partner to MediQuant in their next chapter.

MediQuant’s platform applications are secure, intuitive, and scalable. They provide an active view of patient records within existing systems, which allows customers to reduce security risks and costs by eliminating redundant software applications. MediQuant’s flagship product, DataArk, enables health systems to maintain access to relevant clinical, financial, and administrative data, ensuring that valuable data required for patient care and compliance is secure and within reach. Having been founded more than 20 years ago by pioneers in the data management industry, MediQuant has unmatched expertise, making them a provider of choice for enterprise healthcare organizations.

Revelstoke has deep investment experience in provider data management and recognized that MediQuant’s differentiated platform helps healthcare providers better manage data while achieving a tangible return on investment through reducing application spend, maintaining compliance with regulatory requirements, and increasing physician satisfaction. Revelstoke’s partnership will allow MediQuant to accelerate growth and expand their scope of customers and capabilities.

Contact the Harris Williams Healthcare & Life Sciences Group or Technology Group to learn more about this client engagement.

Harris Williams is a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality. We approach every engagement with boundless collaboration, pooling expertise and relationships across industries and geographies. For over 30 years, our clients have trusted us to think strategically, execute precisely, and deliver superior outcomes to help them grow.


Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 13th floor, One Angel Court, London EC2R 7HJ, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorised and regulated by the Financial Conduct Authority, number 5408952. Harris Williams Private Capital Advisory Ltd. is an Appointed Representative of Sturgeon Ventures, LLP, which is authorised and regulated by the Financial Conduct Authority number 452811. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is 16th Floor, Marienturm, Taunusanlage 9-10 60329, Frankfurt am Main, Germany (email address: hwgermany@harriswilliams.com). Geschäftsführer/Director: Paul Poggi, VAT No. DE321666994. Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.